BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 11763346)

  • 21. [The assessment of Eo-CSF and cytokines as eosinopoietic factor].
    Kamei T
    Nihon Rinsho; 1993 Mar; 51(3):736-40. PubMed ID: 8492450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors.
    Guthridge MA; Stomski FC; Thomas D; Woodcock JM; Bagley CJ; Berndt MC; Lopez AF
    Stem Cells; 1998; 16(5):301-13. PubMed ID: 9766809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-3, IL-5, and GM-CSF signaling: crystal structure of the human beta-common receptor.
    Murphy JM; Young IG
    Vitam Horm; 2006; 74():1-30. PubMed ID: 17027509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Humoral regulation of eosinophilopoiesis by interleukin-3, granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin-5].
    Sonoda Y
    Nihon Rinsho; 1993 Mar; 51(3):565-70. PubMed ID: 8492428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular structure of the IL-3, GM-CSF and IL-5 receptors.
    Miyajima A
    Int J Cell Cloning; 1992 May; 10(3):126-34. PubMed ID: 1613263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family.
    de Groot RP; Coffer PJ; Koenderman L
    Cell Signal; 1998 Oct; 10(9):619-28. PubMed ID: 9794243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling.
    Broughton SE; Dhagat U; Hercus TR; Nero TL; Grimbaldeston MA; Bonder CS; Lopez AF; Parker MW
    Immunol Rev; 2012 Nov; 250(1):277-302. PubMed ID: 23046136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New approaches in the treatment of asthma.
    Ramshaw HS; Woodcock JM; Bagley CJ; McClure BJ; Hercus TR; Lopez AF
    Immunol Cell Biol; 2001 Apr; 79(2):154-9. PubMed ID: 11264710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translating the biology of β common receptor-engaging cytokines into clinical medicine.
    Pant H; Hercus TR; Tumes DJ; Yip KH; Parker MW; Owczarek CM; Lopez AF; Huston DP
    J Allergy Clin Immunol; 2023 Feb; 151(2):324-344. PubMed ID: 36424209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GM-CSF, IL-3, and IL-5 Family of Cytokines: Regulators of Inflammation.
    Dougan M; Dranoff G; Dougan SK
    Immunity; 2019 Apr; 50(4):796-811. PubMed ID: 30995500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience.
    Varricchi G; Bagnasco D; Ferrando M; Puggioni F; Passalacqua G; Canonica GW
    Ther Adv Respir Dis; 2017 Jan; 11(1):40-45. PubMed ID: 27856823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-3 in the development and function of basophils.
    Varricchi G; Poto R; Marone G; Schroeder JT
    Semin Immunol; 2021 Apr; 54():101510. PubMed ID: 34756806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The βc receptor family - Structural insights and their functional implications.
    Broughton SE; Nero TL; Dhagat U; Kan WL; Hercus TR; Tvorogov D; Lopez AF; Parker MW
    Cytokine; 2015 Aug; 74(2):247-58. PubMed ID: 25982846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the β Common (βc) Family of Cytokines in Health and Disease.
    Hercus TR; Kan WLT; Broughton SE; Tvorogov D; Ramshaw HS; Sandow JJ; Nero TL; Dhagat U; Thompson EJ; Shing KSCT; McKenzie DR; Wilson NJ; Owczarek CM; Vairo G; Nash AD; Tergaonkar V; Hughes T; Ekert PG; Samuel MS; Bonder CS; Grimbaldeston MA; Parker MW; Lopez AF
    Cold Spring Harb Perspect Biol; 2018 Jun; 10(6):. PubMed ID: 28716883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-5: a proeosinophil cytokine mediator of inflammation in asthma and a target for antisense therapy.
    Weltman JK; Karim AS
    Allergy Asthma Proc; 1998; 19(5):257-61. PubMed ID: 9801738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth Factors as Immunotherapeutic Targets in Cardiovascular Disease.
    Mindur JE; Swirski FK
    Arterioscler Thromb Vasc Biol; 2019 Jul; 39(7):1275-1287. PubMed ID: 31092009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms and pharmacological manipulation of eosinophil accumulation in vivo.
    Teixeira MM; Williams TJ; Hellewell PG
    Trends Pharmacol Sci; 1995 Dec; 16(12):418-23. PubMed ID: 8578615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein Translation and Signaling in Human Eosinophils.
    Esnault S; Shen ZJ; Malter JS
    Front Med (Lausanne); 2017; 4():150. PubMed ID: 28971096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of GM-CSF/IL-3/IL-5 signaling by antisense oligodeoxynucleotides targeting the common beta chain of their receptors.
    Allam M; Renzi PM
    Antisense Nucleic Acid Drug Dev; 2001 Oct; 11(5):289-300. PubMed ID: 11763346
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.